Treating Healthy Clinical Trial Participants Fairly

Many medical advances rely on Phase I trials that enroll healthy participants to test the safety of new therapies. These trials raise questions about what makes for a “good” trial and whether participants are compensated fairly for the risks and burdens of the research. This event brings together experts on clinical trial policy to discuss healthy participants’ experiences and good trial governance.

Presenters:
- Jill Fisher, PhD
- Holly Fernandez-Lynch, JD, MBE
Moderator:
- Benjamin Silverman, MD

This session is part of the Health Policy & Bioethics Consortia Series. Learn more about the series at https://bioethics.hms.harvard.edu/events/weekly-consortia/health-policy-bioethics-consortia

Видео Treating Healthy Clinical Trial Participants Fairly канала HMS Center for Bioethics